BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3260538)

  • 1. B lymphocyte markers in multiple myeloma and related plasma cell dyscrasias.
    Ricci C; Coscia G; Bozzone DM; Canavera RM; Baldassi R; Cascio G; Anania A; Marchi L; Verney MM
    Cancer Detect Prev; 1988; 11(3-6):423-32. PubMed ID: 3260538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells].
    Okagawa K; Iguchi K; Iishi Y; Kosaka M
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1205-13. PubMed ID: 3934898
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoglobulin secretion by peripheral blood and bone marrow B cells in patients with multiple myeloma. Studies by the reverse haemolytic plaque assay.
    Dammacco F; Vacca A; Altomare E; Campobasso N
    Clin Exp Immunol; 1984 Sep; 57(3):743-51. PubMed ID: 6380841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulation and differentiation markers in monoclonal gammopathies.
    Ricci C; Cascio G; Canavera R; Basso M; Baldassi R
    Acta Haematol; 1987; 78 Suppl 1():50-5. PubMed ID: 3124450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of immunoglobulin synthesis by lymphocytes in multiple myeloma and benign monoclonal gammopathy.
    Takeshita A
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1195-205. PubMed ID: 3492847
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the origin of the precursor cells in multiple myeloma, Waldenström's macroglobulinaemia and benign monoclonal gammopathy. I. Cytoplasmic isotype and idiotype distribution in peripheral blood and bone marrow.
    Van Camp B; Reynaert P; Broodtaerts L
    Clin Exp Immunol; 1981 Apr; 44(1):82-9. PubMed ID: 6790210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immunoglobulin synthesis by monocytes in multiple myeloma and benign monoclonal gammopathy.
    Takeshita A
    Clin Exp Immunol; 1986 Dec; 66(3):625-32. PubMed ID: 3568450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern.
    Lokhorst HM; Boom SE; Bast BJ; Peters PJ; Tedder TF; Gerdes J; Petersen E; Ballieux RE
    J Clin Invest; 1987 May; 79(5):1401-11. PubMed ID: 3553239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal gammopathies and aging.
    Cohen HJ
    Hosp Pract (Off Ed); 1988 Mar; 23(3A):75-80, 82, 85-9 passim. PubMed ID: 3127410
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of selected laboratory indicators in the differential diagnosis and monitoring of multiple myeloma].
    Maisnar V; Tousková M; Malý J; Krejsek J; Kmonícek M; Kopecký O
    Vnitr Lek; 2002 Apr; 48(4):290-7. PubMed ID: 12061177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal gammopathy as a model for B-cell differentiation: from "paraprotein" to artificial antibodies.
    Bast EJ; van Camp B
    Neth J Med; 1991 Oct; 39(3-4):209-15. PubMed ID: 1791883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interpretation of minimal medullary plasmacytoses in monoclonal dysglobulinemias. Importance of the study of osteomedullary biopsies of semi-thin sections and immunologic marking].
    Canioni D; Kermarec J
    Ann Pathol; 1982; 2(4):279-92. PubMed ID: 6760876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocyte membrane markers in monoclonal gammopathies].
    Mathieu A
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):328-32. PubMed ID: 911460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal gammopathy of undetermined significance: a morphologic and immunophenotypic study of the bone marrow.
    Feiner HD; Bannan M; Marsh E; Chuba JV; Espiritu E; Gottesman SR
    Mod Pathol; 1992 Jul; 5(4):372-9. PubMed ID: 1495943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum free light chain analysis in B-cell dyscrasias.
    Ramasamy I
    Ann Clin Lab Sci; 2007; 37(3):291-4. PubMed ID: 17709698
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody activity of monoclonal immunoglobulins in myeloma, macroglobulinemia and benign gammapathy.
    Waldenström JG
    Med Oncol Tumor Pharmacother; 1986; 3(3-4):135-40. PubMed ID: 3100882
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
    Kelly JJ
    Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the diagnosis and management of myeloma.
    Greipp PR
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):24-45. PubMed ID: 1509293
    [No Abstract]   [Full Text] [Related]  

  • 20. Homing mechanisms in the biology of multiple myeloma.
    Van Camp B; Van Riet I
    Verh K Acad Geneeskd Belg; 1998; 60(3):163-94. PubMed ID: 9803879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.